Design of antiretroviral drug-polymeric nanoparticles laden buccal films for chronic HIV therapy in…
Anti-HIV drug Lamivudine exhibit shorter half-life (2 h) and poor bioavailability (62% in paediatric patients), multiple dosing is required. To overcome the limitations, nanoparticles loaded buccal film was developed for prolonged drug…